{"id":"anti-hypertensive-drug-treatment","safety":{"commonSideEffects":[{"rate":"6.1%","effect":"Dizziness"},{"rate":"5.5%","effect":"Headache"},{"rate":"4.8%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL2108941","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This is achieved through the use of angiotensin II receptor blockers (ARBs), which are a class of medications that are used to treat high blood pressure.","oneSentence":"Blocks the action of angiotensin II at its receptor","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:10:00.947Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT05163158","phase":"NA","title":"CENtral Blood Pressure Targeting: A Pragmatic RAndomized Pilot triaL in Advanced Chronic Kidney Disease","status":"COMPLETED","sponsor":"Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal","startDate":"2022-05-24","conditions":"Chronic Kidney Diseases, Hypertension","enrollment":116},{"nctId":"NCT06059638","phase":"NA","title":"BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT","status":"RECRUITING","sponsor":"Orchestra BioMed, Inc","startDate":"2023-12-27","conditions":"Hypertension, Hypertension, Systolic, Hypertension, Essential","enrollment":500},{"nctId":"NCT04789733","phase":"NA","title":"The GUARDIAN Pilot Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2021-04-27","conditions":"General Surgery","enrollment":80},{"nctId":"NCT07469800","phase":"PHASE3","title":"Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity","status":"NOT_YET_RECRUITING","sponsor":"Innovent Biologics (Suzhou) Co. Ltd.","startDate":"2026-04-01","conditions":"Overweight, Obesity, Hypertensive","enrollment":336},{"nctId":"NCT07458880","phase":"NA","title":"Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2026-03-01","conditions":"Intracerebral Hemorrhage","enrollment":140},{"nctId":"NCT04412096","phase":"PHASE4","title":"Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2020-11-23","conditions":"Glaucoma, OHT - Ocular Hypertension","enrollment":59},{"nctId":"NCT06907147","phase":"NA","title":"SPYRAL GEMINI Pilot Study","status":"RECRUITING","sponsor":"Medtronic Vascular","startDate":"2025-05-01","conditions":"Hypertension, Vascular Diseases, Cardiovascular Diseases","enrollment":175},{"nctId":"NCT06287580","phase":"EARLY_PHASE1","title":"Effects of Antihypertensive Drug Treatment on Brain Blood Flow, Cognition, and Regulation of Nervous System in Older Adults With Hypertension.","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-08-15","conditions":"Essential Hypertension, Older Adults","enrollment":27},{"nctId":"NCT06402968","phase":"","title":"Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"Zeenat Qureshi Stroke Institute","startDate":"2024-06-01","conditions":"Intracerebral Hemorrhage, Stroke, Hypertension","enrollment":1000},{"nctId":"NCT05312892","phase":"PHASE1, PHASE2","title":"Sympathetic Mechanisms in Obesity-Crossover Design","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2022-05-20","conditions":"Obesity, Hypertension","enrollment":12},{"nctId":"NCT07166991","phase":"PHASE3","title":"Anesthesia sTrategy foR Organ Procurement In braiN dEath","status":"RECRUITING","sponsor":"University Hospital, Grenoble","startDate":"2026-02-17","conditions":"Brain-dead Organ Donors","enrollment":270},{"nctId":"NCT07424118","phase":"NA","title":"REMIDEP-HTA Program for Hypertension Remission and Medication Deprescription","status":"NOT_YET_RECRUITING","sponsor":"Evelyn Vanina Re","startDate":"2026-04","conditions":"Essential Hypertension","enrollment":240},{"nctId":"NCT05470439","phase":"NA","title":"My Interprofessional Care Team for Adherence and Research Engagement Disparities","status":"RECRUITING","sponsor":"University of Arizona","startDate":"2023-08-30","conditions":"Medication Adherence, Hypertension","enrollment":217},{"nctId":"NCT07130955","phase":"NA","title":"A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Shanghai Golden Leaf MedTec Co. Ltd","startDate":"2025-08-08","conditions":"Hypertension, CKD - Chronic Kidney Disease","enrollment":236},{"nctId":"NCT07061054","phase":"NA","title":"Netrod-Pilot Study of Renal Denervation With NetrodTM Sixelectrode Radiofrequency RDN System","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Golden Leaf MedTec Co. Ltd","startDate":"2026-04-01","conditions":"Uncontrolled Hypertension","enrollment":20},{"nctId":"NCT07397481","phase":"PHASE4","title":"Clinical Application of Simcyp-Guided Doses of Antihypertensive Drugs in Cirrhotic Patients","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2024-03-01","conditions":"Liver Cirrhosis, Arterial Hypertension","enrollment":40},{"nctId":"NCT05760898","phase":"NA","title":"Improving Hypertension Control in Rheumatoid Arthritis","status":"RECRUITING","sponsor":"Duke University","startDate":"2026-01-16","conditions":"Hypertension, Rheumatoid Arthritis","enrollment":25},{"nctId":"NCT07364175","phase":"NA","title":"A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults","status":"RECRUITING","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2026-01","conditions":"Hypertension, Obesity & Overweight","enrollment":60},{"nctId":"NCT04894877","phase":"","title":"ISCHEMIA-EXTEND (Extended Follow-up)","status":"ACTIVE_NOT_RECRUITING","sponsor":"NYU Langone Health","startDate":"2012-07","conditions":"Cardiovascular Diseases, Coronary Disease, Coronary Artery Disease","enrollment":5391},{"nctId":"NCT07362966","phase":"PHASE4","title":"Effect of Colchicine on Progression of Coronary Atherosclerosis in Patients With TET2-CHIP Variant","status":"NOT_YET_RECRUITING","sponsor":"Shenyang Northern Hospital","startDate":"2026-02-24","conditions":"Colchicine, Coronary Atherosclerosis Management, Clonal Hematopoiesis of Indeterminate Potential","enrollment":120},{"nctId":"NCT05609513","phase":"NA","title":"Integration of Hypertension Management in HIV Care in Uganda","status":"COMPLETED","sponsor":"Infectious Diseases Research Collaboration, Uganda","startDate":"2023-02-06","conditions":"HIV/AIDS, Hypertension","enrollment":87421},{"nctId":"NCT05370599","phase":"PHASE2","title":"Hypertension in Young Adults Trial","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2022-04-15","conditions":"Hypertension","enrollment":36},{"nctId":"NCT06069102","phase":"PHASE4","title":"Optimal Blood Pressure Treatment Thresholds Postpartum","status":"COMPLETED","sponsor":"Alisse Hauspurg","startDate":"2023-11-15","conditions":"Hypertensive Disorder of Pregnancy, Pre-Eclampsia, Hypertension","enrollment":61},{"nctId":"NCT05830305","phase":"NA","title":"MOBILE Health Intervention in IntraCerebral Hemorrhage Survivors","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2023-10-01","conditions":"Intracerebral Hemorrhage, Hypertension","enrollment":140},{"nctId":"NCT06284928","phase":"","title":"Metagenomic Analysis of Gut Microbiota in Untreated and Uncontrolled Hypertensive Patients","status":"COMPLETED","sponsor":"Xinjiang Medical University","startDate":"2019-12-01","conditions":"Hypertension, Gut Microbiota","enrollment":192},{"nctId":"NCT06618521","phase":"NA","title":"Effect of Pilates Exercise Versus Circuit Exercise Training on Gestational Hypertension","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-09-30","conditions":"Gestational Hypertension","enrollment":69},{"nctId":"NCT07272486","phase":"NA","title":"The Use of Virtual Reality and Music Therapy for Hypertensive Urgency","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2024-08-01","conditions":"Hypertensive Urgency, Primary Hypertension","enrollment":130},{"nctId":"NCT07273877","phase":"","title":"A Real-World Study on the Treatment of Hypertension With Netrod-RDN Renal Artery Radiofrequency Ablation System","status":"ENROLLING_BY_INVITATION","sponsor":"Shanghai Golden Leaf MedTec Co. Ltd","startDate":"2025-08-07","conditions":"Hypertension","enrollment":1000},{"nctId":"NCT07269288","phase":"","title":"The Correlation and Mechanistic Study of GGCX Gene With Prognosis in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Peking University Aerospace Center Hospital","startDate":"2026-01-25","conditions":"Acute Ischemic Stroke","enrollment":1500},{"nctId":"NCT06526858","phase":"NA","title":"Early Feasibility Study of \"HyperQureTM RDN System\", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension","status":"RECRUITING","sponsor":"DeepQure Inc.","startDate":"2024-11-21","conditions":"Resistant Hypertension","enrollment":15},{"nctId":"NCT07259733","phase":"NA","title":"Rapid Management of Resistant Hypertension in the Public Health System (Fast Control)","status":"RECRUITING","sponsor":"Instituto Dante Pazzanese de Cardiologia","startDate":"2023-07-15","conditions":"Apparent Resistant Hypertension, Hypertension, High Blood Pressure","enrollment":142},{"nctId":"NCT05732727","phase":"PHASE3","title":"Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease","status":"RECRUITING","sponsor":"University Hospital, Tours","startDate":"2023-03-28","conditions":"Chronic Kidney Disease(CKD), Uncontrolled Hypertension","enrollment":720},{"nctId":"NCT07240909","phase":"PHASE4","title":"Antihypertensive Drug Selection Based on Hemodynamic Phenotypes","status":"NOT_YET_RECRUITING","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2026-01","conditions":"Hypertension","enrollment":240},{"nctId":"NCT06862115","phase":"PHASE3","title":"The Effect of Discontinuation of Renin Angiotensin System Inhibitors on the Perioperative Myocardial Injury in Adult Patients Undergoing Colorectal Cancer Surgery","status":"RECRUITING","sponsor":"Kasr El Aini Hospital","startDate":"2025-03-01","conditions":"Myocardium; Injury, Perioperative/Postoperative Complications, Angiotensin-Converting-Enzyme Inhibitor","enrollment":156},{"nctId":"NCT04401267","phase":"PHASE2","title":"Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2020-10-15","conditions":"Hypertension, Osteonecrosis, Osteonecrosis Due to Drug","enrollment":51},{"nctId":"NCT07222852","phase":"PHASE3","title":"Cardiovascular Protection After Preeclampsia With Enalapril","status":"NOT_YET_RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2025-11-15","conditions":"Preeclampsia, Hypertensive Disorder of Pregnancy, Hypertension","enrollment":60},{"nctId":"NCT05330221","phase":"NA","title":"Project 2: ACHIEVE- HF","status":"RECRUITING","sponsor":"Henry Ford Health System","startDate":"2023-01-18","conditions":"Heart Failure, Hypertension","enrollment":364},{"nctId":"NCT04753840","phase":"NA","title":"Long-term of Remote Ischemic Preconditioning in Patients With Mild Hypertension","status":"RECRUITING","sponsor":"Henan Institute of Cardiovascular Epidemiology","startDate":"2021-07-03","conditions":"Hypertension","enrollment":90},{"nctId":"NCT02472028","phase":"PHASE4","title":"Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-09","conditions":"Cerebrovascular Disorders","enrollment":820},{"nctId":"NCT02188381","phase":"","title":"The Role of Gut Microbiota in Hypertension","status":"COMPLETED","sponsor":"University of Florida","startDate":"2014-07","conditions":"Hypertension","enrollment":292},{"nctId":"NCT04991961","phase":"","title":"Effect of Anti-hypertensive Medications on the Diagnostic Accuracy in Primary Aldosteronism","status":"COMPLETED","sponsor":"Chongqing Medical University","startDate":"2020-09-15","conditions":"Hypertension, Primary Aldosteronism","enrollment":341},{"nctId":"NCT06090890","phase":"PHASE4","title":"Anti-inflammatory Therapy for Recurrent In-stent Restenosis","status":"RECRUITING","sponsor":"Fu Wai Hospital, Beijing, China","startDate":"2023-10-30","conditions":"In-stent Restenosis","enrollment":252},{"nctId":"NCT07108829","phase":"NA","title":"Laparoscopic Adventitial Renal Denervation (RDN) for Refractory Hypertension","status":"NOT_YET_RECRUITING","sponsor":"Henan Institute of Cardiovascular Epidemiology","startDate":"2025-08","conditions":"Refractory Hypertension or Drug-intolerant Hypertension","enrollment":10},{"nctId":"NCT03476616","phase":"PHASE4","title":"Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients","status":"COMPLETED","sponsor":"Hippocration General Hospital","startDate":"2018-09-01","conditions":"Hypertension, Obesity","enrollment":198},{"nctId":"NCT04715568","phase":"PHASE4","title":"Secondhand Tobacco Smoke and Cardiovascular Disease","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2021-03-30","conditions":"Cardiovascular Diseases, Hypertension","enrollment":100},{"nctId":"NCT03453268","phase":"NA","title":"Impact of Reducing Antihypertensive Treatment on Mortality in Frail Subjects With Low Systolic Blood Pressure (SBP).","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-10-02","conditions":"Hypertension","enrollment":1048},{"nctId":"NCT06859359","phase":"NA","title":"Improving Maternal Cardiovascular Outcomes Through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in Nigeria","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2025-06-02","conditions":"Hypertensive Disorder of Pregnancy","enrollment":1200},{"nctId":"NCT03354143","phase":"PHASE2","title":"Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2018-04-10","conditions":"Hypertension","enrollment":85},{"nctId":"NCT07017296","phase":"NA","title":"Microencapsulated Pomegranate Juice as Anti-Hypertensive","status":"COMPLETED","sponsor":"Universidad Autónoma del Estado de Hidalgo","startDate":"2024-08-15","conditions":"Clinical Trial","enrollment":20},{"nctId":"NCT04899206","phase":"","title":"ANGIOTENSIN AGENTS AND REDUCTION OF THE PRESCRIPTION OF ANTIDEPRESSANT DRUGS: A RETROSPECTIVE COHORT STUDY USING REAL-WORLD DATA","status":"WITHDRAWN","sponsor":"Sebastian Videla","startDate":"2021-04-12","conditions":"ACE Inhibitors, ARB, Hypertension","enrollment":""},{"nctId":"NCT06964217","phase":"","title":"Immediate Fracture Risk After Antihypertensive Drug Initiation","status":"NOT_YET_RECRUITING","sponsor":"Ajou University School of Medicine","startDate":"2025-06-01","conditions":"Hypertension, Fracture","enrollment":10000000},{"nctId":"NCT06495710","phase":"NA","title":"Arterial Stiffness and Blood Pressure","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2025-05-01","conditions":"Hypertension, Vascular Stiffness, Aging","enrollment":228},{"nctId":"NCT06292585","phase":"NA","title":"Acute EpiDural Hematoma Treated With Middle Meningeal Artery Embolization: a Randomized Trial (AEDH-MT)","status":"RECRUITING","sponsor":"Changhai Hospital","startDate":"2024-09-02","conditions":"EpiDural Hematoma, Traumatic Brain Injury","enrollment":194},{"nctId":"NCT06823570","phase":"NA","title":"Anti-hypertensive Therapy and Exercise Treatment to Improve Vascular Health in Patients With Hypertension.","status":"RECRUITING","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2025-04-01","conditions":"Hypertension, Vascular Function, Fitness Testing","enrollment":60},{"nctId":"NCT03193333","phase":"PHASE3","title":"PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)","status":"TERMINATED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2017-11-06","conditions":"Primary Open-angle Glaucoma","enrollment":51},{"nctId":"NCT04637152","phase":"PHASE2","title":"Sacubitril/Valsartan in Resistant Hypertension","status":"COMPLETED","sponsor":"Hospital Geral Roberto Santos","startDate":"2020-11-11","conditions":"Resistant Hypertension, Blood Pressure","enrollment":80},{"nctId":"NCT06780696","phase":"","title":"SMART Study in Real World","status":"NOT_YET_RECRUITING","sponsor":"SyMap Medical (Suzhou), Ltd.","startDate":"2025-02","conditions":"Hypertension, Uncontrolled Hypertension, Resistant Hypertension","enrollment":1000},{"nctId":"NCT00303459","phase":"PHASE4","title":"Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)","status":"COMPLETED","sponsor":"Actelion","startDate":"2006-05","conditions":"Pulmonary Arterial Hypertension","enrollment":334},{"nctId":"NCT04893733","phase":"PHASE4","title":"Intravenous Administration of Vitamin B Complex Improves Renal Recovery in Patients With AKI","status":"COMPLETED","sponsor":"Caja Nacional de Salud","startDate":"2020-09-01","conditions":"Acute Kidney Injury","enrollment":260},{"nctId":"NCT06801249","phase":"PHASE4","title":"Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome","status":"RECRUITING","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2021-02-23","conditions":"Adrenal Incidentalomas, Cushing Syndrome","enrollment":50},{"nctId":"NCT06284213","phase":"","title":"Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2021-09-29","conditions":"Cognitive Impairment, Dementia","enrollment":1892},{"nctId":"NCT06780865","phase":"NA","title":"Protecting Renal Function in Chronic Kidney Disease Patients with Isolated Nighttime Hypertension","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Institute of Hypertension","startDate":"2025-01-30","conditions":"Chronic Kidney Disease(CKD), Nocturnal Hypertension","enrollment":200},{"nctId":"NCT04035824","phase":"PHASE4","title":"Gastrodia and Uncaria Recipe in Treating Stage-one Hypertension: an Evidence-based Optimization Study","status":"COMPLETED","sponsor":"Shanghai Institute of Hypertension","startDate":"2019-10-08","conditions":"Hypertension","enrollment":605},{"nctId":"NCT04137549","phase":"","title":"Registry Study on \"Control Nocturnal Hypertension to Reach the Target \"","status":"RECRUITING","sponsor":"Shanghai Institute of Hypertension","startDate":"2019-12-01","conditions":"Nocturnal Hypertension","enrollment":4500},{"nctId":"NCT06704815","phase":"","title":"Observational Cohort Study Evaluating the Effectiveness of an Educational Program (NGAYDAUTIEN) in Combination With Perindopril and Amlodipine Single-Pill Combination in Hypertensive Patients naïve of Antihypertensive Treatments.","status":"COMPLETED","sponsor":"Servier Affaires Médicales","startDate":"2023-01-31","conditions":"Hypertension","enrollment":400},{"nctId":"NCT05590871","phase":"NA","title":"FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating Hypertension","status":"RECRUITING","sponsor":"Shanghai Hongdian Medical CO., LTD","startDate":"2023-03-31","conditions":"Hypertension","enrollment":180},{"nctId":"NCT06683430","phase":"NA","title":"High Potassium Diet with Spices and Herbs As Salt Substitute for Lowering Blood Pressure in Older Adults: Study Protocol","status":"COMPLETED","sponsor":"Universitas Airlangga","startDate":"2022-05-11","conditions":"Hypertension, Older Adults Institutionalized in Residential Homes","enrollment":62},{"nctId":"NCT06680986","phase":"","title":"Echocardiographic Analysis by Artificial Intelligence in Hypertension","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2022-06-01","conditions":"Arterial Hypertension","enrollment":200},{"nctId":"NCT03808311","phase":"NA","title":"Blood Pressure Control Target in Diabetes","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2019-02-24","conditions":"Blood Pressure Control Target in Diabetes","enrollment":12821},{"nctId":"NCT05683301","phase":"PHASE4","title":"Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India","status":"COMPLETED","sponsor":"Centre for Chronic Disease Control, India","startDate":"2022-08-30","conditions":"Primary Hypertension","enrollment":1981},{"nctId":"NCT06622304","phase":"","title":"Exploring the Effects of Antihypertensive and Lipid-Lowering Drugs on Inflammatory Cytokine Levels","status":"COMPLETED","sponsor":"Guangzhou Institute of Respiratory Disease","startDate":"2024-04-01","conditions":"Hypertension, Dyslipidemias, Inflammatory Response","enrollment":250736},{"nctId":"NCT06619808","phase":"NA","title":"Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases","status":"RECRUITING","sponsor":"Jinling Hospital, China","startDate":"2024-07-29","conditions":"Metabolic Dysfunction-associated Steatotic Liver Disease, Hepatic Steatosis, Non-alcoholic Fatty Liver Diseases","enrollment":150},{"nctId":"NCT04197700","phase":"NA","title":"The PRESSURE CABG Cardiac Surgery Trial","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2022-11-01","conditions":"Coronary Artery Bypass Grafting, Hypotension","enrollment":600},{"nctId":"NCT06600347","phase":"NA","title":"Effect of DASH Diet and Progressive Muscle Relaxation on Cardiovascular Risks in Postmenopausal Women","status":"RECRUITING","sponsor":"Cairo University","startDate":"2024-06-10","conditions":"Cardiovascular Complication","enrollment":90},{"nctId":"NCT05363059","phase":"","title":"Effect of Bariatric Surgery Versus Medical Therapy on Metabolic Syndrome","status":"RECRUITING","sponsor":"Third Military Medical University","startDate":"2010-05-01","conditions":"Metabolic Syndrome","enrollment":200},{"nctId":"NCT00400218","phase":"PHASE3","title":"Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-09-01","conditions":"Hypertension","enrollment":62},{"nctId":"NCT06515678","phase":"","title":"Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Groupe Hospitalier Pitie-Salpetriere","startDate":"2024-05-20","conditions":"Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab","enrollment":9464},{"nctId":"NCT06513650","phase":"","title":"Mechanism-based Therapy of Hypotensive Syncope","status":"RECRUITING","sponsor":"Istituto Auxologico Italiano","startDate":"2024-05-01","conditions":"Syncope, Vasovagal, Neurally-Mediated","enrollment":140},{"nctId":"NCT06510270","phase":"NA","title":"Dapagliflozin in Reducing Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction","status":"NOT_YET_RECRUITING","sponsor":"Aswan University","startDate":"2024-08-01","conditions":"Heart Failure with Preserved Ejection Fraction","enrollment":70},{"nctId":"NCT05479097","phase":"NA","title":"Feasibility Study of a Novel mHealth Application to Enable Community Health Workers to Manage","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2023-02-06","conditions":"Hypertension","enrollment":32},{"nctId":"NCT06501651","phase":"PHASE4","title":"Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy","status":"NOT_YET_RECRUITING","sponsor":"Sichuan Academy of Medical Sciences","startDate":"2024-08-01","conditions":"Essential Hypertension, Type 2 Diabetes, Nephropathy","enrollment":297},{"nctId":"NCT06441591","phase":"PHASE2, PHASE3","title":"Clinical Outcome of Vinpocetine in Diabetic Nephropathy","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2024-07-10","conditions":"Diabetic Kidney Disease, Diabetic Nephropathies","enrollment":64},{"nctId":"NCT04647292","phase":"PHASE2","title":"European Blood Pressure Intensive Control After Stroke","status":"RECRUITING","sponsor":"University College Dublin","startDate":"2024-05-02","conditions":"Ischemic Stroke, Transient Ischemic Attack","enrollment":142},{"nctId":"NCT05846490","phase":"PHASE4","title":"Impact of Obstructive Sleep Apnea (OSA) Treatment on Blood Pressure Control in Chronic Kidney Disease","status":"RECRUITING","sponsor":"University of Sao Paulo","startDate":"2024-01-08","conditions":"Sleep Apnea, Chronic Kidney Diseases","enrollment":150},{"nctId":"NCT05529147","phase":"","title":"The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2022-09-05","conditions":"Hypertension, Frailty, Old Age; Dementia","enrollment":15},{"nctId":"NCT02426502","phase":"NA","title":"Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of British Columbia","startDate":"2016-04","conditions":"End-Stage Renal Disease","enrollment":76},{"nctId":"NCT00006294","phase":"","title":"Genetics of Hypertension Associated Treatments (GenHAT)","status":"COMPLETED","sponsor":"Donna Arnett, 257-5678","startDate":"1999-09","conditions":"Cardiovascular Diseases, Heart Diseases, Hypertension","enrollment":37939},{"nctId":"NCT05673135","phase":"NA","title":"The Outcomes of Hypertension in Obese Versus Non-obese Pregnant Women","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-04-01","conditions":"Hypertension in Pregnancy","enrollment":260},{"nctId":"NCT04615624","phase":"PHASE3","title":"Furosemide vs. Placebo for Severe Antepartum Hypertension","status":"COMPLETED","sponsor":"Melanie Maykin, MD","startDate":"2021-01-04","conditions":"Pre-Eclampsia, Hypertension in Pregnancy, Pregnancy Complications","enrollment":65},{"nctId":"NCT05291546","phase":"PHASE1","title":"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN9035 in Healthy Adult Volunteers and Mildly Hypertensive Participants","status":"COMPLETED","sponsor":"Regeneron Pharmaceuticals","startDate":"2022-04-13","conditions":"Healthy Volunteers","enrollment":93},{"nctId":"NCT02654964","phase":"PHASE1","title":"Cancer Stem Cell High-Throughput Drug Screening Study","status":"COMPLETED","sponsor":"Swedish Medical Center","startDate":"2015-12","conditions":"Glioblastoma Multiforme","enrollment":9},{"nctId":"NCT06275763","phase":"PHASE4","title":"Optimal Medical Treatment of Difficult-to-treat Hypertension","status":"UNKNOWN","sponsor":"National Institute of Cardiology, Warsaw, Poland","startDate":"2023-10-20","conditions":"Hypertension","enrollment":2500},{"nctId":"NCT04030234","phase":"NA","title":"Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) Study","status":"COMPLETED","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2019-09-17","conditions":"Hypertension","enrollment":11255},{"nctId":"NCT04347330","phase":"NA","title":"Cardiovascular Risk Reduction in Atrial Fibrillation Trial","status":"UNKNOWN","sponsor":"Beijing Anzhen Hospital","startDate":"2020-08-31","conditions":"Atrial Fibrillation, Hypertension","enrollment":1675},{"nctId":"NCT03207100","phase":"NA","title":"Analgesia-first Minimal Sedation for Spontaneous Intracerebral Hemorrhage Early Antihypertensive Treatment","status":"COMPLETED","sponsor":"Hong Yang","startDate":"2017-12-06","conditions":"Early Systolic Blood Pressure Control Rate, Hematoma Growth, Blood Pressure Variability","enrollment":338},{"nctId":"NCT04346511","phase":"PHASE2","title":"Acupuncture Treatment on Cerebral Blood Flow","status":"WITHDRAWN","sponsor":"University of Oklahoma","startDate":"2020-05-09","conditions":"High Blood Pressure","enrollment":""},{"nctId":"NCT06112925","phase":"NA","title":"Impact of Medication Therapy Management Intervention on Treatment Outcomes and Medication Adherence Among Adult Patients Comorbid With Diabetes Mellitus and Hypertension at Outpatient Clinics","status":"COMPLETED","sponsor":"Mattu University","startDate":"2022-03-27","conditions":"Diabetes Mellitus, Hypertension","enrollment":386},{"nctId":"NCT05966025","phase":"PHASE2","title":"Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)","status":"UNKNOWN","sponsor":"October 6 University","startDate":"2023-12-28","conditions":"Fatty Liver Disease, Fatty Liver","enrollment":60},{"nctId":"NCT04116112","phase":"PHASE2","title":"Blood Pressure After Endovascular Stroke Therapy-II","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2020-01-17","conditions":"Acute Stroke, Endovascular Thrombectomy","enrollment":120},{"nctId":"NCT04307836","phase":"NA","title":"DENEX, Renal Denervation Therapy, in Patients With Hypertension on no or 1-3 Antihypertensive Medications","status":"UNKNOWN","sponsor":"Kalos Medical","startDate":"2020-07-09","conditions":"Hypertension, Vascular Diseases, Cardiovascular Diseases","enrollment":140}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":26,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Thiazide Diuretics","Aldosterone receptor antagonist","Beta-blockers","ACE inhibitors","Angiotensin receptor blockers"],"phase":"phase_2","status":"active","brandName":"Anti-hypertensive drug treatment","genericName":"Anti-hypertensive drug treatment","companyName":"Universidade Gama Filho","companyId":"universidade-gama-filho","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Blocks the action of angiotensin II at its receptor Used for Hypertension.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}